Star Health & Allied Insurance Co. Ltd. (IN:STARHEALTH)
:STARHEALTH
STARHEALTH Stock Chart & Stats
₹459.75
-₹6.80(-1.41%)
At close: 4:00 PM EST
₹459.75
-₹6.80(-1.41%)
Day’s Range― - ―
52-Week Range₹341.15 - ₹533.90
Previous CloseN/A
Volume276.82K
Average Volume (3M)42.40K
Market Cap
₹276.17B
Enterprise Value₹274.87B
Total Cash (Recent Filing)₹0.00
Total Debt (Recent Filing)₹4.70B
Price to Earnings (P/E)52.2
Beta0.80
Next Earnings
Apr 28, 2026EPS Estimate
1.41Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.20
Shares Outstanding588,403,500
10 Day Avg. Volume41,268
30 Day Avg. Volume42,396
Financial Highlights & Ratios
PEG Ratio-1.33
Price to Book (P/B)2.88
Price to Sales (P/S)1.24
P/FCF Ratio15.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)16.26
Revenue Forecast (FY)₹218.48B
Bulls Say, Bears Say
Bulls Say
Consistent Revenue GrowthSustained ~21.7% revenue growth signals durable demand for core health insurance products and expanding policy volumes. Over a multi-quarter horizon this supports underwriting scale, better fixed-cost absorption, and greater pricing flexibility to offset medical inflation and distribution costs.
Improving Profitability MetricsTurnaround from prior losses to positive net margin and mid-single-digit ROE indicates structurally improving underwriting discipline and cost control. Sustained margins enhance internal capital generation, support reserve strengthening and reduce reliance on external equity over coming quarters.
Strong Cash GenerationOperating cash consistently outpacing net income and rising free cash flow imply high quality earnings and liquidity buffer. Reliable cash generation underpins reserve funding, reinsurance purchases, product investments and supports resilience to claim spikes over a multi‑quarter horizon.
Bears Say
Volatile Earnings Per ShareSharp negative EPS growth reflects volatility in earnings drivers such as claims timing, large-loss volatility or reserve adjustments. Continued EPS swings complicate capital planning, investor visibility and may force conservative underwriting or higher reinsurance cessions to stabilise results.
Underwriting Exposure To Medical InflationConcentration in health insurance leaves margins exposed to structural medical cost inflation, fraud and utilisation trends. Persistent claim-cost pressure can erode underwriting profitability unless pricing, medical management and provider contract leverage keep pace over multiple quarters.
Past Leveraging Risks Despite ReductionWhile leverage has materially declined, prior periods of higher debt highlight historical balance sheet stress. A modest capital cushion remains important; adverse claim shocks or reserve strengthening could still require capital actions if profitability or cash generation weaken.
Star Health & Allied Insurance Co. Ltd. News
STARHEALTH FAQ
What was Star Health & Allied Insurance Co. Ltd.’s price range in the past 12 months?
Star Health & Allied Insurance Co. Ltd. lowest stock price was ₹341.15 and its highest was ₹533.90 in the past 12 months.
What is Star Health & Allied Insurance Co. Ltd.’s market cap?
Star Health & Allied Insurance Co. Ltd.’s market cap is ₹276.17B.
When is Star Health & Allied Insurance Co. Ltd.’s upcoming earnings report date?
Star Health & Allied Insurance Co. Ltd.’s upcoming earnings report date is Apr 28, 2026 which is in 19 days.
How were Star Health & Allied Insurance Co. Ltd.’s earnings last quarter?
Star Health & Allied Insurance Co. Ltd. released its earnings results on Jan 28, 2026. The company reported ₹2.2 earnings per share for the quarter, missing the consensus estimate of ₹2.422 by -₹0.222.
Is Star Health & Allied Insurance Co. Ltd. overvalued?
According to Wall Street analysts Star Health & Allied Insurance Co. Ltd.’s price is currently Overvalued.
Does Star Health & Allied Insurance Co. Ltd. pay dividends?
Star Health & Allied Insurance Co. Ltd. does not currently pay dividends.
What is Star Health & Allied Insurance Co. Ltd.’s EPS estimate?
Star Health & Allied Insurance Co. Ltd.’s EPS estimate is 1.41.
How many shares outstanding does Star Health & Allied Insurance Co. Ltd. have?
Star Health & Allied Insurance Co. Ltd. has 588,403,500 shares outstanding.
What happened to Star Health & Allied Insurance Co. Ltd.’s price movement after its last earnings report?
Star Health & Allied Insurance Co. Ltd. reported an EPS of ₹2.2 in its last earnings report, missing expectations of ₹2.422. Following the earnings report the stock price went up 3.414%.
Which hedge fund is a major shareholder of Star Health & Allied Insurance Co. Ltd.?
Currently, no hedge funds are holding shares in IN:STARHEALTH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Star Health & Allied Insurance Co. Ltd.
Star Health and Allied Insurance Company Limited provides health insurance products. It offers retail health products to various customer segments, including individuals, families, students, and senior citizens, as well as persons with pre-existing medical conditions across the middle-market customer segment; and group health insurance policies provide to employees of corporates, including SMEs through company health insurance plans. The company also provides personal accident and travel insurance. It distributes its products through individual agents, brokers, corporate agent banks, other corporate agents, and online channel partners comprising web aggregators, as well as directly to customers. As of September 30, 2021, the company had 779 health insurance branches across 25 states and 5 union territories in India. Star Health and Allied Insurance Company Limited was incorporated in 2005 and is based in Chennai, India.
Technical Analysis
Alembic Pharmaceuticals Limited
―
HealthCare Global Enterprises Ltd.
―
Marksans Pharma Limited
―
Global Health Limited
―
Medi Assist Healthcare Services Limited
―